Short-form Ron is a novel determinant of ovarian cancer initiation and progression

Short-form Ron (sfRon) is an understudied, alternative isoform of the full-length Ron receptor tyrosine kinase. In contrast to Ron, which has been shown to be an important player in many cancers, little is known about the role of sfRon in cancer pathogenesis. Here we report the striking discovery th...

Descripción completa

Detalles Bibliográficos
Autores principales: Moxley, Katherine M., Wang, Luyao, Welm, Alana L., Bieniasz, Magdalena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4979590/
https://www.ncbi.nlm.nih.gov/pubmed/27551332
http://dx.doi.org/10.18632/genesandcancer.109

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4979590/
https://www.ncbi.nlm.nih.gov/pubmed/27551332
http://dx.doi.org/10.18632/genesandcancer.109

Ejemplares similares